On Sunday, the Dutch government announced its action against Nexperia, which specializes in chips used in vehicles and consumer electronics, citing concerns over potential technology transfers to its Chinese parent company, Wingtech.
Wingtech was placed on a U.S. “entity list” in December 2024 due to its alleged involvement in aiding China’s government in acquiring sensitive semiconductor manufacturing capabilities. This list was expanded last month to include majority-owned subsidiaries.
Documents from a Dutch court revealed that a June 12 meeting between U.S. Commerce Department officials and the Dutch Foreign Ministry indicated increasing pressure to replace Nexperia’s Chinese CEO to avoid being added to the entity list. The meeting minutes stated, “The fact that the company’s CEO is still the same Chinese owner is problematic,” suggesting that a leadership change was necessary for exemption.
Caught in the crossfire of U.S.-China relations, Nexperia faces export restrictions from both governments and is actively seeking discussions. Following a Dutch court order, the company appointed a new interim CEO after the removal of former CEO Zhang Xuezheng.
The Amsterdam Commercial Court documents indicated that Nexperia had been warned by the Dutch Economic Affairs Ministry on June 5 about potential U.S. regulatory changes that could adversely impact its business. Nexperia is one of the world’s largest manufacturers of basic chips, essential for various electronic products, with its primary production facility located in Hamburg, Germany, while most of its packaging and assembly occurs in China.
In response to the Dutch measures, Wingtech informed its investors that it does not anticipate immediate disruptions to its production or research activities and is pursuing a legal appeal. A source close to the matter stated that company executives believe Dutch authorities are yielding to U.S. pressure but remain optimistic about reversing the decision.
Despite these claims, the Dutch government asserted that there was no U.S. involvement or pressure in its decision to intervene in Nexperia.
